Peroxisome Proliferator-Activated Receptor-γ Calls for Activation in Moderation: Lessons from Genetics and Pharmacology-Reference-Cited by-同舟云学术

Peroxisome Proliferator-Activated Receptor-γ Calls for Activation in Moderation: Lessons from Genetics and Pharmacology

Published:2004-12-01 Issue:6 Volume:25 Page:899-918
ISSN:0163-769X
Container-title:Endocrine Reviews
language:en
Short-container-title:

Author:

Knouff Chris¹,Auwerx Johan¹²

Affiliation:

1. Institut de Génétique et de Biologie Moléculaire et Cellulaire (C.K., J.A.), Centre National de la Recherche Scientifique/Institut National de la Santé et de la Recherche Médicale/Université Louis Pasteur, 67404 Illkirch, France

2. Institut Clinique de la Souris (J.A.), Génopole Strasbourg, 67404 Illkirch, France

Publisher

The Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/edrv/article-pdf/25/6/899/10334520/edrv0899.pdf

Reference217 articles.

1. Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors.;Dreyer;Cell,1992

2. Identification of two mPPAR related receptors and evidence for the existence of five subfamily members.;Chen;Biochem Biophys Res Commun,1993

3. Nuclear receptors and the control of metabolism.;Francis;Annu Rev Physiol,2003

4. Recent advances in peroxisome proliferator-activated receptor science.;Shearer;Curr Med Chem,2003

5. Nuclear receptors and lipid physiology: opening the X-files.;Chawla;Science,2001

Cited by 238 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Advanced Glycation End-Products and Oxidative Stress in Type-2-Diabetes-Induced Bone Fragility and Implications on Fracture Risk Stratification;Antioxidants;2023-04-14

2. Metformin: A Promising Antidiabetic Medication for Cancer Treatment;Current Drug Targets;2023-01

3. A PPARG Splice Variant in Granulosa Cells Is Associated with Polycystic Ovary Syndrome;Journal of Clinical Medicine;2022-12-08

4. Identification of Selective PPAR-γ Modulators by Combining Pharmacophore Modeling, Molecular Docking, and Adipogenesis Assay;Applied Biochemistry and Biotechnology;2022-10-20

5. Associations of peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism with non-alcoholic fatty liver disease: A meta-analysis;Journal of Diabetes and its Complications;2022-10